Valproate – MIMS – New precautionary measures for male patients
01/05/2024
Medicines for human use
Safety update
This article was produced by the HPRA for publication in the May 2024 edition of Monthly Index of Medical Specialties (MIMS) and describes new precautionary measures regarding the potential risk of neurodevelopmental disorders in children of fathers treated with valproate in the three months before conception